Rick Ferris, DO
Obstetrics & Gynecology · Allison Park, PANPI 1962501221
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Genentech, Inc. at 56.6% of the total. Reporting peaked in 2024 at $2,254 and has fallen 86.3% since, to $309 in 2025. Among obstetrics & gynecology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $44.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$2K
- AbbVie$375
- Astellas Pharma US Inc$371
- Organon$149
- Exeltis, USA Inc.$116
- Hologic Sales And Service, LLC$96
- plus $501 from 15 others
What the payments were for
- Consulting fees$2,09657%
- Food & beverage$1,44239%
- Education$1654%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 1 | $2,096 |
| AbbVie(2 entities) | 18 | $375 |
| Astellas Pharma US Inc | 18 | $371 |
| Organon | 8 | $149 |
| Exeltis, USA Inc. | 7 | $116 |
| Hologic Sales And Service, LLC | 6 | $96 |
| Pfizer | 5 | $80 |
| Sage Therapeutics, LLC | 3 | $72 |
| Merck | 4 | $62 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Amgen | 2 | $35 |
| Radius Health, Inc. | 1 | $27 |
| Smith+Nephew | 1 | $27 |
| Medicem Inc. | 1 | $24 |
| Meditrina | 1 | $22 |
| Urovant Sciences Inc | 1 | $20 |
| Shield Therapeutics Inc | 1 | $20 |
| Kedrion Biopharma, Inc. | 1 | $19 |
| Lupin Inc. | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
How this compares
$3,703 in reported general payments places this provider in the 90th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 15 | $9,260 |
| PremarinEstrogens, Conjugated | 22 | $9,078 |
| PremproEstrogen,con/M-Progest Acet | 19 | $4,751 |
| Estradiol | 65 | $3,620 |
| EvistaRaloxifene Hcl | 13 | $2,421 |
| FyavolvNorethindrone Ac/Eth Estradiol | 23 | $1,045 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 13 | $911 |
| Raloxifene Hcl | 19 | $832 |
| Oxybutynin Chloride ErOxybutynin Chloride | 27 | $829 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 37 | $553 |
| Clobetasol Propionate | 14 | $481 |
| Sumatriptan Succinate | 11 | $115 |
| Hydrocortisone | 14 | $109 |
| Fluconazole | 14 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin, Prempro | $80 | $13,82941 claims |
| Astellas Pharma US IncMyrbetriq | $371 | $9,26015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Other obstetrics & gynecology in Allison Park
- Stephen KlaskoPhiladelphia$2.2M
- Stephanie SoberPhiladelphia$1.8M
- Barry JacobsonGlen Mills$302K
- Timothy GrubeFrackville$260K
- Russell StankiewiczLewisburg$202K
- Jamille Nagtalon-RamosPhiladelphia$183K
- Timothy DeimlingMechanicsburg$182K
- Gerald HarkinsMechanicsburg$140K
- Kirthik ParthasarathyWest Reading$103K
- Catherine ChappellPittsburgh$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.